Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ASCLF

Ascletis Pharma Inc.

USD

Set alert

Price alert · ASCLF

All alert types
0.72 USD 0.00 0.00%
As of Oct 29, 2026
0.72 Day range 0.72
0.72 52-week range 2.50
YTD
-51.68%
1 year
-40.00%
Open
0.72
Prev close
0.72
Mkt cap
756.97M
Vol
5.00K
Avg vol
934
EPS
-0.08
P/E
0.00
More statistics
Low
0.72
High
0.72
Earnings
Aug 31, 2026

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for ASCLF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

15.63 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -28.9×
FY 2016: -174×FY 2017: -43.2×FY 2018: -491×FY 2019: -30.2×FY 2020: -12.4×FY 2021: -0.2×FY 2022: -13.1×FY 2023: -9.2×FY 2024: -5.8×FY 2025: -28.9×
FY 2016 5y median -9.2× FY 2025
P/S 5129×
FY 2016: 142×FY 2017: 82.2×FY 2018: 21.6×FY 2019: 27.5×FY 2020: 73.7×FY 2021: 0.5×FY 2022: 76.2×FY 2023: 22.7×FY 2024: 1364×FY 2025: 5129×
FY 2016 5y median 76.2× FY 2025
P/B 5.2×
FY 2016: 17.1×FY 2017: 7.3×FY 2018: 1.0×FY 2019: 1.4×FY 2020: 0.9×FY 2021: 0.0×FY 2022: 1.6×FY 2023: 0.5×FY 2024: 0.9×FY 2025: 5.2×
FY 2016 5y median 0.9× FY 2025
P/FCF -30.6×
FY 2016: -81.8×FY 2017: -18.7×FY 2018: -31.9×FY 2019: -46.5×FY 2020: -20.8×FY 2021: -0.2×FY 2022: -26.3×FY 2023: -7.9×FY 2024: -5.1×FY 2025: -30.6×
FY 2016 5y median -7.9× FY 2025
EV/EBITDA -19.2×
FY 2016: -106×FY 2017: -40.5×FY 2018: -3.1×FY 2019: -24.3×FY 2020: 0.7×FY 2021: 14.5×FY 2022: -5.8×FY 2023: -7.6×FY 2024: -2.3×FY 2025: -19.2×
FY 2016 5y median -5.8× FY 2025
EV/Sales 4400×
FY 2016: 129×FY 2017: 70.8×FY 2018: 2.5×FY 2019: 10.3×FY 2020: -3.8×FY 2021: -32.0×FY 2022: 30.6×FY 2023: 17.0×FY 2024: 695×FY 2025: 4400×
FY 2016 5y median 30.6× FY 2025
FCF Yield -3.3%
FY 2016: -1.2%FY 2017: -5.3%FY 2018: -3.1%FY 2019: -2.1%FY 2020: -4.8%FY 2021: -442.1%FY 2022: -3.8%FY 2023: -12.7%FY 2024: -19.6%FY 2025: -3.3%
FY 2016 5y median -12.7% FY 2025

Profitability

Gross Margin -842.7%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 92.6%FY 2019: 71.7%FY 2020: -67.1%FY 2021: 51.0%FY 2022: -45.6%FY 2023: 45.9%FY 2024: 57.3%FY 2025: -842.7%
FY 2016 5y median 45.9% FY 2025
Operating Margin -23854.0%
FY 2016: -129.6%FY 2017: -185.3%FY 2018: -80.5%FY 2019: -21.0%FY 2020: -620.3%FY 2021: -292.6%FY 2022: -635.9%FY 2023: -530.4%FY 2024: -23025.6%FY 2025: -23854.0%
FY 2016 5y median -635.9% FY 2025
Net Margin -17745.6%
FY 2016: -81.3%FY 2017: -101.4%FY 2018: -4.4%FY 2019: -55.3%FY 2020: -597.8%FY 2021: -258.9%FY 2022: -582.1%FY 2023: -255.7%FY 2024: -23455.7%FY 2025: -17745.6%
FY 2016 5y median -582.1% FY 2025
ROE -18.1%
FY 2016: -9.8%FY 2017: -9.0%FY 2018: -0.2%FY 2019: -2.9%FY 2020: -7.0%FY 2021: -7.3%FY 2022: -12.4%FY 2023: -6.2%FY 2024: -15.3%FY 2025: -18.1%
FY 2016 5y median -12.4% FY 2025
ROIC -24.2%
FY 2016: -9.2%FY 2017: -11.1%FY 2018: -3.9%FY 2019: -1.1%FY 2020: -7.3%FY 2021: -8.2%FY 2022: -13.5%FY 2023: -12.7%FY 2024: -14.9%FY 2025: -24.2%
FY 2016 5y median -13.5% FY 2025
ROA -17.0%
FY 2016: -5.0%FY 2017: -5.4%FY 2018: -0.2%FY 2019: -2.8%FY 2020: -6.8%FY 2021: -7.0%FY 2022: -11.8%FY 2023: -5.8%FY 2024: -14.2%FY 2025: -17.0%
FY 2016 5y median -11.8% FY 2025

Growth (YoY)

Revenue 54.0%
FY 2016: 0.0%FY 2017: 61.3%FY 2018: 212.6%FY 2019: 4.3%FY 2020: -79.8%FY 2021: 119.6%FY 2022: -29.6%FY 2023: 4.6%FY 2024: -97.7%FY 2025: 54.0%
FY 2016 FY 2025
Operating Income -59.5%
FY 2016: 0.0%FY 2017: -130.6%FY 2018: -35.8%FY 2019: 72.8%FY 2020: -495.8%FY 2021: -3.6%FY 2022: -52.9%FY 2023: 12.7%FY 2024: 1.6%FY 2025: -59.5%
FY 2016 FY 2025
EPS (diluted) -20.0%
FY 2016: 0.0%FY 2017: -277.8%FY 2018: 90.7%FY 2019: -1685.7%FY 2020: -33.3%FY 2021: 10.0%FY 2022: -61.1%FY 2023: 55.2%FY 2024: -130.8%FY 2025: -20.0%
FY 2016 FY 2025
Free Cash Flow 3.7%
FY 2016: 0.0%FY 2017: -309.8%FY 2018: 52.0%FY 2019: 8.7%FY 2020: -20.8%FY 2021: -24.4%FY 2022: -1.8%FY 2023: -4.1%FY 2024: -110.5%FY 2025: 3.7%
FY 2016 FY 2025

Financial Health

Current Ratio 15.1×
FY 2016: 6.3×FY 2017: 8.8×FY 2018: 36.0×FY 2019: 36.4×FY 2020: 38.4×FY 2021: 28.9×FY 2022: 23.5×FY 2023: 16.6×FY 2024: 12.9×FY 2025: 15.1×
FY 2016 5y median 16.6× FY 2025
Quick Ratio 15.0×
FY 2016: 6.1×FY 2017: 8.2×FY 2018: 35.1×FY 2019: 35.4×FY 2020: 37.6×FY 2021: 28.3×FY 2022: 23.3×FY 2023: 16.5×FY 2024: 12.8×FY 2025: 15.0×
FY 2016 5y median 16.5× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 3.2×
FY 2016: 10.4×FY 2017: 6.5×FY 2018: 24.2×FY 2019: 40.5×FY 2020: 14.9×FY 2021: 14.7×FY 2022: 8.7×FY 2023: 2.6×FY 2024: 2.2×FY 2025: 3.2×
FY 2016 5y median 3.2× FY 2025
Interest Coverage -2950×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -200×FY 2020: -1608×FY 2021: -1800×FY 2022: -2191×FY 2023: -2085×FY 2024: 0.0×FY 2025: -2950×
FY 2016 5y median -2085× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 1.4%FY 2017: 0.0%FY 2018: 1.6%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: -240.5%FY 2017: 0.0%FY 2018: -796.6%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31